Holen Sie sich die Stockscreener-App
15.22
3.67%
-0.58
Handel nachbörslich:
15.11
-0.11
-0.72%
Immunovant Inc Aktie (IMVT) Neueste Nachrichten
(IMVT) Investment Analysis - news.stocktradersdaily.com
Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Wells Fargo & Company MN - Defense World
A company insider recently sold 1,925 shares of Immunovant Inc [IMVT]. Should You Sale? - knoxdaily.com
IMVT’s Stock Market Adventure: -34.80% YTD Growth Amidst Volatility - investchronicle.com
Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial - openPR.com
Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharma - Barchart.com
Perhaps timely catching Immunovant Inc (IMVT) would be a good idea - Sete News
Immunovant registers shares for selling stockholders - MSN
Potential Price Increase for Immunovant Inc (IMVT) After Recent Insider Activity - knoxdaily.com
Market Watch Highlights: Immunovant Inc (IMVT) Ends on an Downturn Note at 14.72 - DWinneX
Stock Market Recap: Immunovant Inc (IMVT) Concludes at 14.58, a -7.60 Surge/Decline - DWinneX
Immunovant, Inc. (NASDAQ:IMVT) Receives $38.33 Average PT from Analysts - Defense World
Immunovant’s (IMVT) “Neutral” Rating Reiterated at UBS Group - Defense World
Immunovant Inc [IMVT] Records 50-Day SMA of $18.03 - knoxdaily.com
All change at Immunovant as Pete Salzmann retires - The Pharma Letter
UBS Downgrades Immunovant to Neutral, Price Target is $17 - marketscreener.com
Upward Trajectory: Immunovant Inc (IMVT) Posts a Slidee, Closing at 14.46 - DWinneX
Trial of Sjögren's treatment IMVT-1402 slated to launch in summer - Sjogren's Syndrome News
Roivant Tightens Leadership Grip On Immunovant, Narrows Near-Term IMVT-1402 Focus - insights.citeline.com
Immunovant Announces Roivant President Eric Venker As New CEO: Retail’s Elated - NewsBreak: Local News & Alerts
Immunovant Names New CEO, CFO - marketscreener.com
Roivant Sciences Announces Leadership Changes at Immunovant - TipRanks
Immunovant Announces New CEO Amid Strategic Shift - TipRanks
Immunovant (IMVT) Appoints New CEO Amid Strategic Changes - GuruFocus
Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications - TradingView
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 - The Manila Times
Immunovant (IMVT) Announces Leadership Changes - StreetInsider
Immunovant's Major Growth Push: Drug Pipeline Hits 6 Indications as Roivant Executive Takes CEO Role - Stock Titan
Alliancebernstein L.P. Grows Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant Executives Sell Shares to Cover Tax Obligations - TradingView
(IMVT) On The My Stocks Page - news.stocktradersdaily.com
Geode Capital Management LLC Boosts Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Thyroid Eye Disease Market Predicted to See Upsurge Through - openPR.com
Wellington Management Group LLP Lowers Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant CEO Peter Salzmann sells shares worth $364,941 By Investing.com - Investing.com South Africa
Raymond James Financial Inc. Takes Position in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Immunovant CEO Peter Salzmann sells shares worth $364,941 - Investing.com
Immunovant CEO Peter Salzmann Sells Shares to Cover Tax Obligations - TradingView
JPMorgan Chase & Co. Has $28.57 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant stock hits 52-week low at $13.58 amid market challenges - Investing.com Australia
Immunovant stock hits 52-week low at $13.58 amid market challenges By Investing.com - Investing.com South Africa
Is Immunovant, Inc. (IMVT) the Best Low Cost Stock to Buy According to Billionaires? - Insider Monkey
Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Sei Investments Co. - Defense World
Raymond James Financial Inc. Makes New $505,000 Investment in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Norges Bank Purchases Shares of 637,947 Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Did an AI Discriminate in Hiring? Employer Faces Lawsuit - Law.com
Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Vanguard Group Inc. - Defense World
Immunovant, Inc. (NASDAQ:IMVT) Stock Holdings Lowered by Corebridge Financial Inc. - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 10,800 Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant is Now Oversold (IMVT) - Nasdaq
Teacher Retirement System of Texas Has $377,000 Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Analysts Set Immunovant, Inc. (NASDAQ:IMVT) PT at $41.00 - Defense World
How the (IMVT) price action is used to our Advantage - news.stocktradersdaily.com
Immunovant stock hits 52-week low at $17.01 amid market challenges - Investing.com
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):